Solomon A Mensah1,2, Alina A Nersesyan1, Eno E Ebong3,4,5. 1. Department of Bioengineering, Northeastern University, Boston, MA, USA. 2. Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA, USA. 3. Department of Bioengineering, Northeastern University, Boston, MA, USA. e.ebong@northeastern.edu. 4. Department of Chemical Engineering, Northeastern University, 360 Huntington Avenue, 335 Interdisciplinary Science and Engineering Complex, Boston, MA, 02115, USA. e.ebong@northeastern.edu. 5. Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, USA. e.ebong@northeastern.edu.
Abstract
PURPOSE: The endothelial glycocalyx (GCX) plays a critical role in the health of the vascular system. Degradation of the GCX has been implicated in the onset of diseases like atherosclerosis and cancer because it disrupts endothelial cell (EC) function that is meant to protect from atherosclerosis and cancer. Examples of such EC function include interendothelial cell communication via gap junctions and receptor-mediated interactions between endothelial and tumor cells. This review focuses on GCX-dependent regulation of these intercellular interactions in healthy and diseased states. The ultimate goal is to build new knowledge that can be applied to developing GCX regeneration strategies that can control intercellular interaction in order to combat the progression of diseases such as atherosclerosis and cancer. METHODS: In vitro and in vivo studies were conducted to determine the baseline expression of GCX in physiologically relevant conditions. Chemical and mechanical GCX degradation approaches were employed to degrade the GCX. The impact of intact versus degraded GCX on intercellular interactions was assessed using cytochemistry, histochemistry, a Lucifer yellow dye transfer assay, and confocal, intravital, and scanning electron microscopy techniques. RESULTS: Relevant to atherosclerosis, we found that GCX stability determines the expression and functionality of Cx43 in gap junction-mediated EC-to-EC communication. Relevant to cancer metastasis, we found that destabilizing the GCX through either disturbed flow-induced or enzyme induced GCX degradation results in increased E-selectin receptor-mediated EC-tumor cell interactions. CONCLUSION: Our findings lay a foundation for future endothelial GCX-targeted therapy, to control intercellular interactions and limit the progression of atherosclerosis and cancer.
PURPOSE: The endothelial glycocalyx (GCX) plays a critical role in the health of the vascular system. Degradation of the GCX has been implicated in the onset of diseases like atherosclerosis and cancer because it disrupts endothelial cell (EC) function that is meant to protect from atherosclerosis and cancer. Examples of such EC function include interendothelial cell communication via gap junctions and receptor-mediated interactions between endothelial and tumor cells. This review focuses on GCX-dependent regulation of these intercellular interactions in healthy and diseased states. The ultimate goal is to build new knowledge that can be applied to developing GCX regeneration strategies that can control intercellular interaction in order to combat the progression of diseases such as atherosclerosis and cancer. METHODS: In vitro and in vivo studies were conducted to determine the baseline expression of GCX in physiologically relevant conditions. Chemical and mechanical GCX degradation approaches were employed to degrade the GCX. The impact of intact versus degraded GCX on intercellular interactions was assessed using cytochemistry, histochemistry, a Lucifer yellow dye transfer assay, and confocal, intravital, and scanning electron microscopy techniques. RESULTS: Relevant to atherosclerosis, we found that GCX stability determines the expression and functionality of Cx43 in gap junction-mediated EC-to-EC communication. Relevant to cancer metastasis, we found that destabilizing the GCX through either disturbed flow-induced or enzyme induced GCX degradation results in increased E-selectin receptor-mediated EC-tumor cell interactions. CONCLUSION: Our findings lay a foundation for future endothelial GCX-targeted therapy, to control intercellular interactions and limit the progression of atherosclerosis and cancer.
Authors: Donna L Cioffi; Subha Pandey; Diego F Alvarez; Eugene A Cioffi Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-03-02 Impact factor: 5.464
Authors: G T Sukhikh; M M Ziganshina; N V Nizyaeva; G V Kulikova; J S Volkova; E L Yarotskaya; N E Kan; A I Shchyogolev; V L Tyutyunnik Journal: Placenta Date: 2016-05-10 Impact factor: 3.481
Authors: Solomon A Mensah; Ian C Harding; Michelle Zhang; Michael P Jaeggli; Vladimir P Torchilin; Mark J Niedre; Eno E Ebong Journal: AIChE J Date: 2019-05-09 Impact factor: 3.993
Authors: Sebastian Beyer; Anna Blocki; Matthew Chung Yin Cheung; Zoe Ho Ying Wan; Babak Mehrjou; Roger Dale Kamm Journal: Life (Basel) Date: 2021-02-25